Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology).
about
Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide.Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer DatabaseThe combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.Population-based survival data for brain tumors in Korea.Assessment and treatment relevance in elderly glioblastoma patients.Temozolomide and radiotherapy versus radiotherapy alone in high grade gliomas: a very long term comparative study and literature review.Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registriesIDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients.Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcomeRadiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology).A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme.Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis.Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions.Patterns of care and survival for glioblastoma patients in the Veterans population.Bevacizumab in glioblastoma multiforme.Comparison between poor and long-term survivors with glioblastoma: review of an Australian dataset.Treating glioblastoma patients with poor performance status: where do we go from here?A practical grading system of ultrasonographic visibility for intracerebral lesions.Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors.Prognostic factors for glioblastoma patients--a clinical population-based study.Cost-effectiveness analysis of FET PET-guided target selection for the diagnosis of gliomas.Glioblastoma management in the temozolomide era: have we improved outcome?Survival of European patients with central nervous system tumors.Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.Glioblastoma in elderly patients: solid conclusions built on shifting sand?Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group.Personalized surgical therapy.Neuro-oncology practices in Australia: a Cooperative Group for Neuro-Oncology patterns of care study.Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylation.
P2860
Q30447260-478319B3-8227-417B-B542-AB63947958FDQ33775341-619F5D2A-DC00-4E26-A2A1-CFAF98B1364CQ34061985-7F65BB0E-9D92-4111-8FC1-E37A01ED57ECQ34290509-9152B5FD-FEC8-4E58-8803-3C365B576F39Q34359650-0E214370-187F-45AE-B474-446DC7AEEE2AQ35177942-AAEF0352-C17D-45EC-93EF-F4C577B54D1DQ35605776-3329287B-F276-4374-80C2-29F1C69B3419Q35686908-B9D1BAB6-7C9A-473B-B8C5-CDC7458CC68DQ35845223-C6310F30-4033-40E6-99F0-75DBE79CA4BDQ36010125-924E2041-EE97-42B2-AE09-0956137F9C3BQ36179190-6E446927-7A6A-4C3F-A86D-AB11F45E94D3Q36411906-8BC62AAD-8AF9-42CE-97CE-13EB524FAC79Q37672546-AE72C9A5-167D-4990-85B2-3CEEEB23F638Q37924635-94DAB3C0-E5E9-4EA3-9B40-C0138A3C4294Q37965628-0909F669-1CBE-47B2-99F0-F7A1EF4ADD5EQ38108888-DC4319A2-B7B2-42F9-8CC2-6A2BEEA989EEQ38233183-7A48B625-0EF5-487C-916F-CC3BB530414AQ39200475-303436AE-B640-44A3-8591-EFEC5FBC86F7Q39611554-5DCE9C59-307E-43E3-A4F4-9C619F9E725EQ41377266-DE30C3C1-F19F-4FF3-8A1A-459091D6A921Q43461278-2C95C80C-1592-4113-976E-3EF3B92BEAC8Q44000206-2BB9CE7E-7C9D-4591-90F2-C2295AC109ADQ44379781-F453CF6F-A058-45EC-AF1E-AEAC28668642Q44517700-7639655A-1C36-4BEE-A7FE-4717073C6E64Q47827482-EA50084E-608D-465B-9F8B-5677DD29298EQ48279219-19E298C4-A149-4C83-BA36-67324D795104Q48365755-DF295F7F-4A47-4985-AEAD-1F9A4111F4F9Q50183147-D4D37950-45D2-4E70-B4C8-CAD0B3F8AC9CQ55461298-5BC4D879-3BE8-490A-87EA-7B1C05971F06
P2860
Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Patterns of care and survival ...... iation of Radiation Oncology).
@en
Patterns of care and survival ...... ous System Study Group of Airo
@nl
type
label
Patterns of care and survival ...... iation of Radiation Oncology).
@en
Patterns of care and survival ...... ous System Study Group of Airo
@nl
prefLabel
Patterns of care and survival ...... iation of Radiation Oncology).
@en
Patterns of care and survival ...... ous System Study Group of Airo
@nl
P2093
P50
P1433
P1476
Patterns of care and survival ...... iation of Radiation Oncology).
@en
P2093
Beatrice Detti
Costantino De Renzis
Cristina Mantovani
Filippo Bertoni
Franco Berti
Giampaolo Biti
Giovanni Rubino
Guido Sotti
Laura Fariselli
Lucia Fatigante
P304
P356
10.1227/01.NEU.0000371990.86656.E8
P407
P577
2010-08-01T00:00:00Z